Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Neovii Pharmaceuticals AG – Swiss Biotech
Neovii Pharmaceuticals 2026 Company Profile: Valuation, Investors ...
Change of CEO at Neovii Pharmaceuticals | The Pharmaletter
Neovii Pharmaceuticals AG Establishes Global Scientific Department ...
Neovii - Partners - Fannin Ltd
Who we are | Neovii
Homepage | Neovii
Neovii and Fosun Pharma Enter Into an Exclusive Agreement | Newswire
Scandinavian Biopharma and Neovii extend and expand their distribution ...
Neovii success story - Franz Ziel GmbH
Neovii and Fosun Pharma Enter into an Exclusive Agreement for ...
Leadership change and even more momentum: Biotech pioneer Neovii under ...
I am excited to share great news that Neovii has started for COVID-19 ...
Neovii Biotech GmbH Medizintechnik Sanoliste
Neovii Pharmaceuticals names its new CEO | Healthcare Digital
Neovii Pharmaceuticals AG Headquarters | Neovii
What we do | Neovii
Research and Development | Neovii
Neovii Grafalon (Anti-Human T-Lymphocyte Immunoglobulin), For Hospital ...
Careers | Neovii
NEOVII Partners with Tel Aviv University to Develop Novel COVID-19 ...
Neovii and Fosun Pharma Enter into an Exclusive Agreement | Neovii
Neovii & Mundipharma Confirm In-licensing Agreement for the Development ...
Neovii & Fosun Pharma ink agreement for bringing transplantation ...
Neovii se asocia con la Universidad de Tel Aviv para desarrollar una ...
General Terms and Conditions | Neovii
Neovii | LinkedIn
Neovii
Leadership | Neovii
Neovii Pharmaceuticals AG Announces New CEO
News & Events | Neovii
Neovii & Mundipharma Agreement for Solid Organ & Stem Cell Transplant
Neovii Biotech GmbH (Gräfelfing) im Ranking der deutschen Top ...
Privacy Policy | Neovii
NEOVII - Photos & Vidéos
Neovii Pharmaceuticals AG announces new CEO | Presseportal
Grafalon 20mg/ml Neovii - Thuốc dự phòng và điều trị thải ghép
Neovii Biotech GmbH (Neovii Biotech GmbH) - 药物管线_专利_临床试验_投融营收_最新药物:抗人T ...
Entreprise de Sécurité - Surveillance à Villette-d'Anthon | NEOVII
Führungswechsel bei Neovii Pharmaceuticals | Presseportal
Neovii: Long-term Outcomes After Standard Graft-Versus-Host Disease ...
Medical Devices, Pharma Supply & Scientific Equipment - Fannin Ltd
Neovii, Strength: 20 g at ₹ 39995/vial in Ahmedabad | ID: 2855805007548
复星医药与Neovii签订协议于中国独家销售及开发Grafalon®（抗人T细胞兔免疫球蛋白） （2022年9月7日，中国上海和瑞士拉珀斯维尔 ...
Scandinavian Biopharma expands its product portfolio with an ...
Strategic Partner – Allmed
Scientific Program - Ewog Symposium
Pharmaceuticals | Muscat Pharmacy & Stores LLC
Biotechnology - HealthCorp Partners
Immunology and Cellular Therapies in Autoimmune Diseases | EBMT
卡妥索单抗(Catumaxomab)-药物靶点：CD3 + EpCAM_在研适应症：胃癌，膀胱癌，结直肠癌_专利_临床_研发
Health Care
25 berühmte deutsche Chemiker und ihre Erfolge für die Wissenschaft ...
Distribution – Scandinavian Biopharma
Enterprise-Grade Customizable Solutions Provider | About Us
PMEBTP, CV et Offres d'emploi dédiés aux carrières du BTP
Excited to have participated in the TTS Congress with our esteemed ...
Sponsoren - Fortbildungsportal
GxP-konforme Software » Dokumenten- & Qualitätsmanagement
复星医药与Neovii签订协议于中国独家销售及开发Grafalon®（抗人T细胞兔免疫球蛋白）_集团新闻_新闻中心_复星医药-持续创新 乐享健康
